SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION

Lobbying Spend

—

Filings

Firms Hired

Active Period

2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
ALB SOLUTIONS	—	4

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Food & Drug Administration (FDA)	3
HOUSE OF REPRESENTATIVES	3
Health & Human Services, Dept of (HHS)	3
SENATE	3

Most frequently reported lobbying issues

Issue Code	Description	Reports
Tariff (miscellaneous tariff bills)	Tariff (miscellaneous tariff bills)	4
Trade (domestic/foreign)	Trade (domestic/foreign)	4
Manufacturing	Manufacturing	4

SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION — Lobbying Disclosure | Poliscope